Around the world, the pandemic is all anyone can talk about. All eyes are on the
spread of the virus. The crisis is challenging families, communities, health care systems, and governments.
This page brings together several initiatives and response measures by IPE Global through its various
projects to help manage and mitigate the virus risk.
A much needed session on Adolescent Mental Health! The esteemed panelists include Dr. Sanjay Chugh, Senior Consultant Psychiatrist, M.D. (Psychiatry), M.B.B.S. & Dr. Vijay Datta, Principal, Modern School, Barakhamba Road, New Delhi and the event will be moderated by Mr. Yogi Suri, Publisher, Milap Publications.
The Norway India Partnership Initiative (NIPI) aims to help identify and test novel and promising healthcare solutions in its effort to support State National Health Missions of five states in India: Bihar, Madhya Pradesh, Odisha, Rajasthan and Jammu & Kashmir. As an unexpected yet result of this partnership has been the development of a triaging tool for detecting COVID-19 suspect cases.
To address the stigma attached to Covid-19 patients, MoHFW invited development partners including Norway India Partnership Initiative (NIPI) for technical and programmatic support. In consensus with development partners, MOHFW identified the National Anti-stigma and Discrimination Campaign as a key strategy.
Misinformation and hesitancy towards COVID-19 vaccination have been reported as two main factors impacting the pace of vaccination in India. However, the six districts of Rajasthan have a different story to tell with re-opening of Skilling centres after the second lockdown.
Though governments are more cautious in announcing lockdowns this year, it has unsettled the workers who are yet to recover from the earlier jolt. Gripped with fear and panic, they have all started rushing home in huge numbers.
India’s ambitious target of vaccinating at least all its adult population by the end of 2021 seems too optimistic. Approximate calculations indicate that to vaccinate this near 945 million adults, India will need a minimum of 1.89 billion doses.